Skip to main content
SpringerLink
Log in

Clinical Aspects of Breast Cancer

  • Chapter
Hormones and Cancer

Part of the book series: Hormones in Health and Disease ((HHD))

Abstract

Except for skin cancer, breast cancer is the most common malignancy in women. It accounts for approximately one-third of cancers in females in the United States. In 1994, the American Cancer Society estimated that 182,000 new cases of breast cancer would be diagnosed in women and 46,000 women would die of the disease. In contrast, breast cancer in males is rare, with only 1000 new diagnoses and 300 cancer-related deaths expected in 1994 (Boring et al., 1994).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adair F, Berg J, Joubert L, Robbins JF (1974): Long term follow-up of breast cancer patients. The 30 year report. Cancer 33: 1145–1150

    PubMed  CAS  Google Scholar 

  • American Joint Committee on Cancer (1988): Breast cancer. In: Manual for Staging of Cancer, Beahrs OH, Henson DE, Hutter RVP, Meyers MH, eds. Philadelphia: JB Lippincott, 3rd Ed

    Google Scholar 

  • Analysis at six years by Nolvadex Adjuvant Trial Organization (1985): Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Lancet 1: 836–839

    Google Scholar 

  • Andersen J A (1977): Lobular carcinoma in situ of the breast. Long term follow-up. Cancer 39: 2597–2602

    PubMed  CAS  Google Scholar 

  • Ashikari R, Park K, Huvos AG, Urban JA (1970): Paget’s disease of the breast. Cancer 26: 680–686

    PubMed  CAS  Google Scholar 

  • Attia-Sobol J, Ferriere JP, Cure H, Kwiatkowski F, Achard JL, Verrelle P, Feillel V, DeLatour M, Lafaye C, Deloach C, Dauplat J, Dely A, Rozan R, Chollet P (1993): Treatment results, survival and prognositic factors in 109 inflammatory breast cancers: univariate and multivariate analyses. Eur J Cancer 29A: 1081–1088

    Google Scholar 

  • Barone P, Moore M, Kinne D (1990): Occult primary cancer presenting with axillary metastases. Arch Surg 125: 210–214

    Google Scholar 

  • Baum M, Ebb S, Brooks M (1990): Biological fall out from trials of adjuvant tamoxifen in early breast cancer. In: Adjuvant Therapy of Cancer VI, Salmon SE, ed. Philadelphia: WB Saunders

    Google Scholar 

  • Bell D, Hadju S, Urban J (1983): The role of aspiration cytology in the diagnosis and management of mammary lesions in office practice. Cancer 51: 1182–1189

    PubMed  CAS  Google Scholar 

  • Berg JW, Hutter RVP (1995): Breast Cancer. Cancer Suppl 75: 257–269

    CAS  Google Scholar 

  • Blichert-Toft M, Rose C, Andersen J, Overgaard M, Axelsson CK, Andersen KW, Mouridsen HT (1992): Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life table analysis. J Natl Cancer Inst Monogr 11: 19–25

    PubMed  Google Scholar 

  • Bonadonna G (1992): Evolving concepts in the systemic adjuvant treatment of breast cancer. Cancer Res 52: 2127–2137

    PubMed  CAS  Google Scholar 

  • Bonadonna G, Valagussa P, Tancini G, Rossi A, Brambilla C, Zambetti M, Bignami P, Di Fronzo G, Silvestrini R (1986): Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer. Natl Cancer Inst Monogr 1: 45–49

    Google Scholar 

  • Bonadonna G, Veronesi U, Brambilla C, Ferrari L, Luini A, Greco M, Bortoli C, deYoldi C, Zucali R, Rilke F, Andreola S, Silvestrini R, DiFronzo G, Valagussa P (1990): Primary chemotherapy to avoid mastectomies in tumor with diameters of three centimeters or more. J Natl Cancer Inst 82: 1539–1545

    PubMed  CAS  Google Scholar 

  • Boring CC, Squires TS, Tong T, Montgomery S (1994): Cancer statistics 1994. Cancer 44: 7–26

    CAS  Google Scholar 

  • Breast Cancer Trials Committee (1987): Adjuvant tamoxifen in the management of operable breast cancer: the Scottish trial. Lancet 2: 171–175

    Google Scholar 

  • Byar DP, Sears ME, McGuire WL (1979): Relationship between estrogen receptor values and clinical data in predicting the response to endocrine therapy for patients with advanced breast cancer. Eur J Cancer 15: 299–310

    PubMed  CAS  Google Scholar 

  • Carter C, Allen C, Henson D (1989): Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 64: 181–187

    Google Scholar 

  • Chaudry M, Millis R, Hoskins E (1984): Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 71: 711–714

    Google Scholar 

  • Clark G, Osborne CK, McGuire W (1984): Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 2: 1102–1109

    PubMed  CAS  Google Scholar 

  • Clark GM, Mathieu MC, Owens MA, Dressier LG, Eudey L, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff MD, McGuire WL (1992): Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. J Clin Oncol 10: 428–432

    PubMed  CAS  Google Scholar 

  • Claus EB, Risch NJ, Thompson WD (1990): Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131: 961–972

    PubMed  CAS  Google Scholar 

  • Colditz GA (1993): Epidemiology of breast cancer: findings form the Nurses Health Study. Cancer 71: 1480–1489

    PubMed  CAS  Google Scholar 

  • Consensus Conference (1985): Adjuvant chemotherapy for breast cancer. JAMA 254: 3461–3463

    Google Scholar 

  • Consensus Statement (1990): Early stage breast cancer. NIH Consensus Development Conference. June 18 - 21, Vol. 8: 6

    Google Scholar 

  • Daling JR, Malone KE, Voight LF, White E, Weiss NS (1994): Risk of breast cancer among young women: realtionship to induced abortion. J Natl Cancer Inst 86: 1584–1592

    PubMed  CAS  Google Scholar 

  • DeLena M, Varini M, Zucali R, Rovini D, Viganotti G, Valagussa P, Veronesi U, Bonadonna G (1981): Multimodality treatment for locally advanced breast cancer. Results of chemotherapy-radiotherapy versus chemotherapy-surgery. Cancer Clin Trials 4: 229–236

    CAS  Google Scholar 

  • Dupont WD (1994): Evidence of efficacy of mammographic screening for women in their forties. Cancer 74: 1204–1206

    PubMed  CAS  Google Scholar 

  • Dupont WD, Page DL (1985): Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312: 146–151

    PubMed  CAS  Google Scholar 

  • Dupont WD, Pari FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD (1993): Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71: 1258–1265

    PubMed  CAS  Google Scholar 

  • Early Breast Cancer Trialists’ Collaborative Group (1992): Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339: 1–15, 71–85

    Google Scholar 

  • Eddy DM (1992): High-dose chemotherapy with autologous bone marrow trans-plantation for the treatment of metastatic breast cancer. J Clin Oncol 10: 657–670

    PubMed  CAS  Google Scholar 

  • Edeiken S (1988): Mammography and palpable cancer of the breast. Cancer 61: 263–265

    PubMed  CAS  Google Scholar 

  • Elledge RM, Clark GM, Chamness GC, Osborne CK (1994): Tumor biologic factors and breast cancer prognosis among white, hispanic and black women in the U.S. J Natl Cancer Inst 86: 705–712

    PubMed  CAS  Google Scholar 

  • Feldman LD, Hortobagyi GN, Buzdar AU, Ames FC, Blumenschein GR (1986): Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 46: 2578–2581

    PubMed  CAS  Google Scholar 

  • Feuer EJ, Wun LM (1992): How much of the recent rise in breast cancer incidence can be explained by an increase in mammography utilization? Am J Epidemiol 136: 1423–1436

    PubMed  CAS  Google Scholar 

  • Fisher B (1980): Laboratory and clinical research in breast cancer; a personal adventure: the David Karnofsky Memorial Lecture. Cancer Res 40: 3863–3874

    PubMed  CAS  Google Scholar 

  • Fisher B, Ravdin RG, Ausman RK, Slack NH, Moore GE, Noer RJ (1968): Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation. Ann Surg 168: 337–356

    PubMed  CAS  Google Scholar 

  • Fisher B, Carbone PP, Economou SG, Frelick R, Glass A, Lerner H, Redmond C, Zelen M, Bond P, Katrych DL, Wolmark N, Fisher ER (1975a): L-phenylalanine mustard (L-PAM) in the management of primary breast cancer: a report of early findings. N Engl J Med 292: 117–122

    PubMed  CAS  Google Scholar 

  • Fisher B, Slack N, Katrych D, Wolmark N (1975a): Ten-year follow-up of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical chemotherapy. Surg Gynecol Obstet 140: 528–534

    PubMed  CAS  Google Scholar 

  • Fisher B, Redmond C, Fisher E, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R (1985): Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without irradiation. N Engl J Med 311: 674–681

    Google Scholar 

  • Fisher B, Redmond C, Fisher ER, Wolmark N (1986): Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience. Adjuvant chemotherapy and endocrine therapy for breast cancer. Natl Cancer Inst Monogr 1: 35–43

    Google Scholar 

  • Fisher B, Redmond C, Fisher ER, Caplan R (1988): Relative worth of estrogen and progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node-negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 6: 1076–1087

    PubMed  CAS  Google Scholar 

  • Fisher B, Redmond C, Dimitrov NV, Bowman D, Legault-Poisson S, Wickerham DL, Wolmark N, Fisher ER, Margolese R, Sutherland C, Glass A, Foster R, Caplan R (1989a): A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 320: 473–478

    PubMed  CAS  Google Scholar 

  • Fisher B, Constantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL, Fisher ER, Margolese R, Robidoux A, Shibata H, Terz J, Paterson AHG, Feldman MI, Farrar W, Evans J, Lickley HL, Ketne M (1989b): A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen- receptor-positive tumors. N Engl J Med 320: 479–484

    PubMed  CAS  Google Scholar 

  • Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher E, Deutsch M, Caplan R, Pilch Y, Glass A, Shibata H, Lerner H, Terz J, Sidorovich L (1989c): Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320: 822–828

    PubMed  CAS  Google Scholar 

  • Fisher B, Constantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, Wolmark N, Wickerham DL, Deutsch M, Ore L, Mamounes E, Poller E, Kavanah M (1993): Lumpectomy compared with lumpectomy and radiation for the treatment of intraductal breast cancer. N Engl J Med 328: 1581–1586

    PubMed  CAS  Google Scholar 

  • Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S (1993): Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 85: 1644–1656

    PubMed  CAS  Google Scholar 

  • Foote FW, Stewart F (1941): Lobular carcinoma in situ: a rare form of mammary carcinoma. Am J Pathol 17: 491–496

    PubMed  CAS  Google Scholar 

  • Foote FW, Stewart F (1941): Lobular carcinoma in situ: a rare form of mammary carcinoma. Am J Pathol 17: 491–496

    PubMed  CAS  Google Scholar 

  • Fourquet A, Campana F, Zafrani B, Mosseri V, Vielh P, Durand JC, Vilcoq JR (1989): Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25 year follow-up. Int J Rad Oncol Biol Phys 17: 719–725

    CAS  Google Scholar 

  • Freeman C, Belliveau N, Kim T, Boivin JF (1981): Limited surgery with or without radiotherapy for early breast carcinoma. J Can Assoc Radiol 32: 125–128

    PubMed  CAS  Google Scholar 

  • Fumoleau P, Delgado FM, Delozier T, Monnier MA, Delgado G, Kerbrat P, Garcia- Giralt E, Keiling R, Namer M, Closon MT, Goudier MJ, Chollet P, Lecourt L, Monteuquet P (1993): Phase II trial of weekly vinorelbine in first-line advanced breast cancer chemotherapy. J Clin Oncol 11: 1245–1252

    PubMed  CAS  Google Scholar 

  • Garber JE, Henderson IC (1989): The use of chemotherapy in metastatic breast cancer. Hematol Oncol Clin North Am 3: 807–821

    PubMed  CAS  Google Scholar 

  • Garfinkel L, Boring CC, Heath CW (1994): Changing Trends. An overview of breast cancer incidence and mortality. Cancer 74: 222–227

    PubMed  CAS  Google Scholar 

  • Gelber RD, Goldhirsch A (1994): Radiotherapy to the conserved breast: is it avoidable if the cancer is small? J Natl Cancer Inst 86: 652 - 653

    PubMed  CAS  Google Scholar 

  • Gelber RD, Goldhirsch A, Coates AS (1993): Adjuvant therapy for breast cancer: understanding the overview. J Clin Oncol 11: 580–585

    PubMed  CAS  Google Scholar 

  • Ghalie R, Richman CM, Adler SS, Cobleigh MA, Korenblit AD, Manson SD, McCleod BC, Taylor SG, Valentino LA, Wolter J, Kaizer H (1994): Treatment of metastatic breast cancer with a split-course high dose chemotherapy regimen and autologous bone marrow transplantation. J Clin Oncol 12: 342–346

    PubMed  CAS  Google Scholar 

  • Giuliano A, Kirgan D, Guenther J, Morton DL (1994): Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391–401

    PubMed  CAS  Google Scholar 

  • Glick JH, Gelber RD, Goldhirsch A, Senn HJ (1992): Meeting highlights: adjuvant therapy for primary breast cancer. J Natl Cancer Inst 84: 1479–1485

    PubMed  CAS  Google Scholar 

  • Goldgar DE, Fields P, Lewis CM, Tran TD, Cannon-Albright LA, Ward JH, Swensen J, Skolnick MH (1994): A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis. J Natl Cancer Inst 86: 200–209

    PubMed  CAS  Google Scholar 

  • Gregory WM, Smith P, Richards MA, Twelves CJ, Knight RK, Rubens RD (1993): Chemotherapy of advanced breast cancer: outcome and prognostic factors. Br J Cancer 68: 1988–1995

    Google Scholar 

  • Haagensen CD (1971): The natural history of breast carcinoma. In: Diseases of the Breast, Philadelphia: WB Saunders Haagensen CD, Bodian C, Haagensen DE (1981): Lobular neoplasia (lobular carcinoma in situ). In: Breast Carcinoma: Risk and Detection. Philadelphia: WB Saunders

    Google Scholar 

  • Hall JM, Lee MK, Morrow J, Anderson L, Huey B, King MC (1990): Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689

    PubMed  CAS  Google Scholar 

  • Hankey BF, Miller B, Curtis R, Kosary C (1994): Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst Monogr 16: 7–14

    PubMed  Google Scholar 

  • Harris M, Howell A, Chrissohou M, Swindell R, Hudson M, Sellwood R (1984): A comparison of the metastatic pattern of infiltrating lobular and infiltrating duct carcinoma of the breast. Br J Cancer 50: 23–30

    PubMed  CAS  Google Scholar 

  • Harris JR, Lippman ME, Veronesi U, Willet W (1992): Breast Cancer. N Engl J Med 327: 319–328

    PubMed  CAS  Google Scholar 

  • Harris JR, Morrow M, Bonadonna G (1993): Cancer of the Breast. In: Cancer. Principles and Practice of Oncology, DeVita VT, Hellman S, Rosenberg SA, eds. Philadelphia: JB Lippincott

    Google Scholar 

  • Harris JR, Morrow M (1996): Local management of invasive breast cancer. In: Diseases of the Breast, Harris JR, Lippman ME, Morrow M, Hellman S, eds. Philadelphia: Lippincott Raven

    Google Scholar 

  • Henderson IC (1991): Principles in the mangement of metastatic breast cancer. In: Breast Diseases, 2nd ed, Harris JR, Hellman S, Henderson IC, Kinne DW, eds. Philadelphia: JB Lippincott

    Google Scholar 

  • Henderson IC, Hayes DF, Gelman R (1988): Dose-response in the treatment of breast cancer: a critical review. J Clin Oncol 6:1501–1515 Henderson IC, Garber JE, Breitmeyer JB (1990): Comprehensive management of disseminated breast cancer. Cancer 66: 1439–1448

    Google Scholar 

  • Hetelekidis S, Schnitt S, Morrow M, Harris JR (1995): Management of ductal carcinoma in situ. CA Cancer J Clinicians 45: 244–253

    CAS  Google Scholar 

  • Holford TR, Roush GC, McKay LA (1991): Trends in female breast cancer in Connecticut and the United States. J Clin Epidemiol 44: 29–39

    PubMed  CAS  Google Scholar 

  • Holland R, Veling S, Mravunac M, Hendriks J (1985): Histologic multifocality of Tis, Tl-2 breast carcinomas: implications for clinical trials of breast conserving treatment. Cancer 56: 979–990

    PubMed  CAS  Google Scholar 

  • Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B (1994): Ductal carcinoma in situ: a proposal for a new classification. Sem Diag Pathol 11: 167–180

    CAS  Google Scholar 

  • Hortobagyi GN, Frye D, Buzdar AU, Hug V, Fraschini G (1988): Complete remissions in metastatic breast cancer: a thirteen year follow-up report. Proc Am Soc Clin Oncol 7: 37

    Google Scholar 

  • Jacquemier J, Kurtz J, Amalric R, Brandone H, Ayme Y, Spitalier J (1990): An assessment of extensive intraductal component as a risk factor for local recurrence after breast conserving therapy. Br J Cancer 61: 873–876

    PubMed  CAS  Google Scholar 

  • Jacquiilat C, Baillat F, Weil M, Auclerc G, Housset M, Aucler MF, Sellami M, Jindani A, Thill L, Soubrane C, Khayat D (1988): Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (Illa-IIIb). Cancer 61: 1977–1982

    Google Scholar 

  • Jaiyesimi I A, Buzdar AU, Hortobagyi G (1992): Inflammatory breast cancer: a review. J Clin Oncol 10: 1014–1024

    PubMed  CAS  Google Scholar 

  • Jensen EV, Block GE, Smith S, Kyser K, DeSombre ER (1971): Estrogen receptors and breast cancer response to adrenalectomy. Natl Cancer Inst Monogr 34: 55–70

    PubMed  CAS  Google Scholar 

  • Kaluzny AD, Rimer B, Harris R (1994): The National Cancer Institute and Guideline Development: lessons from the breast cancer screening controversy. J Natl Cancer Inst 86: 901–905

    PubMed  CAS  Google Scholar 

  • Kearney T, Morrow M (1995): Effect of re-excision on the success of breast conserving therapy. Ann Surg Oncol 2: 303–307

    PubMed  CAS  Google Scholar 

  • Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL (1995): Efficacy of screening mammography. A meta-analysis. JAMA 273: 149–154

    PubMed  CAS  Google Scholar 

  • Kopans DB, Halpern E, Hulka CA (1994): Statistical power in breast cancer screening trials and mortality reduction among women 40–49 years of age with particular emphasis on the National Breast Screening Study of Canada. Cancer 74: 1196–1204

    PubMed  CAS  Google Scholar 

  • Lagios M, Richards V, Rose M, Yee E (1983): Segmental mastectomy without radiotherapy. Short-term follow-up. Cancer 52: 2173–2179

    PubMed  CAS  Google Scholar 

  • Legha SS, Powell K, Davis HL, Muggia FM (1978): Hormonal therapy of breast cancer: new approaches and concepts. Ann Inter Med 88: 69–77

    CAS  Google Scholar 

  • Leis HP, Dursi J, Mersheimer WL (1967): Nipple discharge. Significance and treatment. NY State J Med 67: 3105–3110

    Google Scholar 

  • Lennington WJ, Jensen RA, Dalton LW, Page DL (1994): Ductal carcinoma in-situ of the breast: heterogeneity of individual lesions. Cancer 73: 118–124

    PubMed  CAS  Google Scholar 

  • Lesser ML, Rosen PP, Kinne DW (1982): Multicentricity and bilaterality in invasive breast carcinoma. Surgery 91: 234–240

    PubMed  CAS  Google Scholar 

  • Lichter A, Lippman M, Danforth D, d’Angelo T, Steinberg SM, deMoss E, McDonald HD, Reichert CM, Merino M, Swain SM, Cowan K, Gerber LH, Bader LH, Findlay PA, Schain W, Gorrell C, Straus K, Rosenberg S, Glatstein E (1992): Mastectomy versus breast conserving therapy in the treatment of Stage I and II carcinoma of the breast. A randomized trial at the National Cancer Institute. J Clin Oncol 10: 976–983

    PubMed  CAS  Google Scholar 

  • Liljegren G, Holmberg L Adami O, Westman G, Graffman S, Bergh J, Uppsala-Orebro Breast Cancer Study Group (1994): Sector resection with or without post-operative radiotherapy for stage I breast cancer: five-year results of a randomized trial. J Natl Cancer Inst 86: 717–722

    Google Scholar 

  • Lynch HT, Watson P, Conway T, Fitzsimmons ML, Lynch J (1988): Breast cancer family history as a risk factor for breast cancer. Breast Cancer Res Treat 11: 263–267

    PubMed  CAS  Google Scholar 

  • Maddox W, Carpenter J, Laws H, Soong SJ, Cloud G, Urist MM, Balch CM (1983): A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann Surg 198: 207–212

    PubMed  CAS  Google Scholar 

  • Mansi JL, Berger U, McDonnel T, Pople A, Rayter Z, Gazet JC, Coombes RC (1989): The fate of bone marrow of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 7: 445–449

    PubMed  CAS  Google Scholar 

  • Mansour EG, Gray R, Shatila AH, Osborne CK, Tormey DC, Gilchrist KW, Cooper MR, Falkson G (1989): Efficacy of adjuvant chemotherapy in high-risk, node-negative breast cancer: an intergroup study. N Engl J Med 320: 485–490

    PubMed  CAS  Google Scholar 

  • Matthews R, McNeese M, Montague E, Oswald MJ (1988): Prognostic implicationsm of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy. Int J Rad Oncol Biol Phys 14: 659–663

    CAS  Google Scholar 

  • McCormick B, Rosen PP, Kinne DW, Cox L, Yahalom J (1991): Ductal carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. Int J Rad Oncol Biol Phys 21: 289–292

    CAS  Google Scholar 

  • McGuire WL, Vollmer EP, Carbone PP (1975): Estrogen Receptors in Human Breast Cancer. New York, Raven Press

    Google Scholar 

  • McGuire WL, Tandon AK, Allred DC, Chamness GC, Ravdin PM, Clark GM (1992): Prognosis and treatment decisions in patients with breast cancer without axillary node involvement. Cancer 70: 1755–1781

    Google Scholar 

  • Mendoza CB, Moore GE, Crosswhite LH, Sanberg AA, Watne AL (1969): Prognostic significance of tumor cells in the bone marrow. Surg Gynecol Obstet 129: 483–488

    PubMed  Google Scholar 

  • Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering

    Google Scholar 

  • L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994): A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71

    Google Scholar 

  • Miller BA, Feuer EJ, Hankey BF (1994): The significance of rising incidence of breast cancer in the United States. In: Important Advances in Oncology, DeVita YT, Hellman S, Rosenberg SA, eds. Philadelphia: JB Lippincott

    Google Scholar 

  • Morrison AS (1993): Screening for breast cancer. Epidemiol Rev 15: 244–255

    PubMed  CAS  Google Scholar 

  • Morrow M (1990): Management of nonpalpable breast lesions. In: PPO Updates, DeVita VT, Hellman S, Rosenberg SA, eds. Philadelphia: JB Lippincott Morrow M (1991): Nipple discharge. In: Breast Diseases, Harris JR, Hellman S, Henderson IC, Kinne DW, eds. Philadelphia: JB Lippincott Morrow M, Braverman A, Thelmo W, Sohn CK, Sand J, Mora M, Forlenza T, Marti J (1986): Multimodal therapy for locally advanced breast cancer. Arch Surg 121: 1291–1296

    Google Scholar 

  • Morrow M, Quiet C, Hellman S, Hassett C, Schmidt R, Ewing C (1994a): Treatment selection in breast cancer: are our biases correct? Proc Am Soc Clin Oncol 13: 99

    Google Scholar 

  • Morrow M, Schmidt R, Cregger B, Hassett C, Cox S (1994b): Preoperative evaluation of abnormal mammographic findings to avoid unnecessary breast biopsy. Arch Surg 129: 1091–1096

    PubMed  CAS  Google Scholar 

  • Morrow M, Schnitt S (1996): Lobular carcinoma in situ. In: Diseases of the Breast, Harris JR, Lippman ME, Morrow M, Hellman S, eds. Philadelphia: Lippincott Raven

    Google Scholar 

  • Morrow M, Harris JR, Schnitt S (1996): Ductal carcinoma in situ. In: Diseases of the Breast, Harris JR, Lippman ME, Morrow M, Hellman S, eds. Philadelphia: Lippincott Raven

    Google Scholar 

  • Nattinger A, Gottleib M, Verum J, Yahnke D, Goodwin JS (1992): Geographic variation in the use of breast conserving treatment for breast cancer. N Engl J Med 326: 1102–1107

    PubMed  CAS  Google Scholar 

  • Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murph GP (1980): Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45: 2917–2924

    PubMed  CAS  Google Scholar 

  • Noone RB, Frazier TG, Noone GC (1994): Recurrence of breast carcinoma following immediate reconstruction: a 13-year review. Plast Reconst Surg 93: 96–106

    PubMed  CAS  Google Scholar 

  • Osborne M, Ormiston N, Harmer C, McKinna J, Baker J, Greening W (1984): Breast conservation in the treatment of early breast cancer. A 20 year follow-up. Cancer 53: 349–352

    PubMed  CAS  Google Scholar 

  • Page DL, Dupont WD, Rogers LW, Landenberger M (1982): Intraductal carcinoma of the breast. Follow-up after biopsy only. Cancer 49: 751–758

    PubMed  CAS  Google Scholar 

  • Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rodgers LW (1991): Lobular neoplasia of the breast: high risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22: 1232–1239

    PubMed  CAS  Google Scholar 

  • Perloff M, Lesnick GJ, Korzun A, Chu F, Holland JF, Thirwell MP, Ellison RR, Carey RW, Leone L, Weinberg V, Rice MA, Wood WC (1988): Combination chemotherapy with mastectomy or radiotherapy for Stage III breast cancer: a Cancer and Leukemia Group B Study. J Clin Oncol 6: 261–269

    PubMed  CAS  Google Scholar 

  • Petit JY, Le MG, Mouriesse H, Rietjens M, Gill P, Contesso G, Lehmann A (1994): Can breast reconstruction with gel-filled silicone implants increase the risk of death and second primary cancer in patients treated by mastectomy for breast cancer? Plast Reconst Surg 94: 115–119

    PubMed  CAS  Google Scholar 

  • Pfieffer P, Cold S, Rose C (1992): Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations? Acta Oncol 31: 219–224

    Google Scholar 

  • Preece P, Baum M, Mansel R, Webster D, Fortt R, Gravelle I, Hughes I (1982): Importance of mastalgia in operable breast cancer. Br Med J 284: 1299–1300

    CAS  Google Scholar 

  • Qualheim R, Gall E (1957): Breast carcinoma with multiple sites of origin. Cancer 10: 460–468

    PubMed  CAS  Google Scholar 

  • Reichman BS, Seidman AD, Crown JPA, Heelan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, Currie V, Hudis CA, Yao TJ, Klecker R, Jamis- Dow C, Collins J, Quinlivan S, Berkery R, Toomasi F, Canetta R, Fisherman J, Arbuck S, Norton L (1993): Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. J Clin Oncol 11: 1943–1951

    PubMed  CAS  Google Scholar 

  • Rose M, Olivotto I, Cady B, Koufman C, Osteen R, Silver B, Recht A, Harris JR (1989): The long-term results of conservative surgery and radiation therapy for early breast cancer. Arch Surg 124: 153–157

    PubMed  CAS  Google Scholar 

  • Rosen P, Fracchia A, Urban J, Schottenfeld D, Robbins GF (1975): “Residual” mammary carcinoma following simulated partial mastectomy. Cancer 35:739–747

    Google Scholar 

  • Rosen PP, Lieberman PH, Braun DW Jr, Kosloff C, Adair F (1978): Lobular carcinoma in situ of the breast. Am J Surg Pathol 2: 225–261

    PubMed  CAS  Google Scholar 

  • Rosen PP (1996): The pathology of invasive breast cancer. In: Diseases of the Breast, Harris JR, Lippman ME, Morrow M, Hellman S, eds. Philadelphia: Lippincott Raven

    Google Scholar 

  • Rosen PP, Braun D, Kinne D (1982): The clinical significance of pre-invasive breast carcinoma. Cancer 49: 751–758

    Google Scholar 

  • Rosen PP, Groshen S, Kinne DW, Hellman S (1993): Factors influencing prognosis in node-negative breast carcinoma: an analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol 11: 2090–2100

    PubMed  CAS  Google Scholar 

  • Rosenberg L (1994): Induced abortion and breast cancer: more scientific data are needed. J Natl Cancer Inst 86: 1569–1570

    PubMed  CAS  Google Scholar 

  • Rosner D, Bedwani RN, Vana J, Baker HW, Murphy GP (1980): Noninvasive breast carcinoma. Results of a national survey by the American College of Surgeons. Ann Surg 192: 139–147

    PubMed  CAS  Google Scholar 

  • Samet J, Hunt W, Farrow D (1994): Determinants of receiving breast conserving surgery. The Surveillance, Epidemiology and End Results Program, 1983–1986. Cancer 73: 2344–2351

    PubMed  CAS  Google Scholar 

  • Santen RJ, Manni A, Harvey H, Redmond C (1990): Endocrine treatment of breast cancer in women. Endocr Rev 11: 221–263

    PubMed  CAS  Google Scholar 

  • Sarrazin D, Le M, Arriagada R, Contesso G, Fontaine F, Spielman M, Rochard F, LeChevalier T, Lacour J (1989): Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 14: 177–184.

    PubMed  CAS  Google Scholar 

  • Sattin RW, Rubin GL, Webster LA, Huezo CM, Wingo PA, Ory HW, Layde PM (1990): Family history and the risk of breast cancer. JAMA 253: 1908–1913

    Google Scholar 

  • Schottenfeld D, Nash AG, Robbins GF, Beattie EJ (1976): Ten-year results of the treatment of primary operable breast carcinoma. A summary of 304 patients evaluated by the TNM system. Cancer 38: 1001–1007

    PubMed  CAS  Google Scholar 

  • Schwartz GF, Finkel GC, Garcia JC, Patchetsky AS (1992): Sub-clinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer 70: 2468–2472

    PubMed  CAS  Google Scholar 

  • Seltzer MH, Perloff LJ, Kelley RI, Fitts WT (1970): The significance of age in patients with nipple discharge. Surg Gynecol Obstet 131: 519–522

    PubMed  CAS  Google Scholar 

  • Silverstein M, Gamagami P, Colburn W, Colburn WJ, Gierson ED, Rosser RJ, Handel H, Waisman JR (1989): Non-palpable breast lesions: diagnosis with slightly over penetrated screen-film mammography and hook wire directed biopsy in 1014 cases. Radiology 171: 633–638

    PubMed  CAS  Google Scholar 

  • Silverstein JM, Cohlan BF, Gierson ED, Furmanski MJ, Gamagami P, Colburn WJ, Lewinsky BS, Waisman JR (1992): Ductal carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 28: 630–634

    PubMed  CAS  Google Scholar 

  • Singeltary SE, McNeese MD, Hortobagyi GN (1992): Feasibility of breast conservation surgery after induction chemotherapy for locally advanced breast cancer. Cancer 69: 2849–2852

    Google Scholar 

  • Smart CR (1994): Breast cancer screening in women 40-49 years of age: data and 14- year followup of the Breast Cancer detection Demonstration Project. Breast Dis 5: 20–25

    Google Scholar 

  • Solin LJ, Recht A, Fourquet A, Kurtz J, Kuske R, McNeese M, McCormick B, Cross M, Schultz D, Bornstein B, Spitalier J, Vilcoq J, Fowble B, Harris J, Goodman R (1991): Ten year results of breast conserving therapy and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer 68: 2337–2344

    PubMed  CAS  Google Scholar 

  • Somlo G, Doroshow JH, Forman SJ, Leong LA, Margolin KA, Morgan RJ, Raschko JW, Akman SA, Ahn C, Sniecinski I (1994): High-dose doxorubicin, etoposide and cyclophosphamide with stem cell reinfusion in patients with metastatic or high risk primary breast cancer. Cancer 73: 1842–1848

    Google Scholar 

  • Strawbridge H, Hassett A, Foldes I (1984): Role of cytology in management of lesions of the breast. Surg Gynecol Obstet 159: 130–132

    Google Scholar 

  • Swanson GM, Raghab NE, Lin CS, Hankey BF, Miller B, Horn-Ross P, White E, Liff JM, Harlan LC, McWhorter WP, Mullan PB, Key CR (1993): Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race, age and extent of disease. Cancer 72: 788–798

    PubMed  CAS  Google Scholar 

  • Teicher BA, Holden SA, Eder JP, Herman TS, Antman KH, Frei E (1990): Preclinical studies relating to the use of thiotepa in the high dose setting alone and in combination. Semin Oncol (suppl 3 ) 17: 18–32

    PubMed  CAS  Google Scholar 

  • The Ludwig Breast Cancer Study Group (1989): Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320: 491–496

    Google Scholar 

  • Turner L, Swindell R, Bell W (1981): Radical versus modified radical mastectomy for breast cancer. Ann R Coll Surg Engl 63: 239–243

    PubMed  CAS  Google Scholar 

  • Urban J, Egeli R (1978): Non lactational nipple discharge. Cancer 28: 3–13

    Google Scholar 

  • Van Dongen J, Bartelink H, Fentiman I, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Winter J, van Zijl K (1992): Randomized clinical trial to assess the value of breast conserving therapy in Stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr 11: 15–18

    PubMed  Google Scholar 

  • Vandenberg TA, Pritchard KI, Eisenhauer EA, Trudeau ME, Norris BD, Lopez P, Verma SS, Buckman RA, Muldal A (1993): Phase II study of weekly edatrexate as first-lie chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study. J Clin Oncol 11: 1241–1244

    PubMed  CAS  Google Scholar 

  • Velentgas P, Daling JR (1994): Risk factors for breast cancer in younger women. Monogr Natl Cancer Inst 16: 15–22

    PubMed  Google Scholar 

  • Veronesi U, Banfi A, Salvadori B, Luini A, Saccozzi R, Zucali R, Marubini E, Del Vecchio M, Boracchi P, Marchini S, Merson M, Sacchini V, Riboldi G, Santoro G (1990a): Breast conservation is the treatment of choice in small breast cancer. Long term results of a randomized clinical trial. Eur J Cancer 26: 668–670

    PubMed  CAS  Google Scholar 

  • Veronesi U, Volterrani F, Luini A, Saccozzi R, Del Vecchio M, Zucali R, Galimbert V, Rasponi A, Di Re E, Squicciarini P, Salvadori B (1990b): Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26: 671–673

    PubMed  CAS  Google Scholar 

  • Vezzoni P, Balestrazzi A, Bignami P (1979): Axillary lymph node metastases from occult carcinoma of the breast. Tumori 65: 87–91

    PubMed  CAS  Google Scholar 

  • Vicini F, Recht A, Abner A, Boyages J, Cady B, Connolly JL, Gelman R, Osteen RT, Schnitt SJ, Silen W (1992): Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. J Natl Cancer Inst Monogr 11: 33 - 39

    PubMed  Google Scholar 

  • Vogelstein B, Kinzler KW (1994): Has the breast cancer gene been found? Cell 79: 1–3

    PubMed  CAS  Google Scholar 

  • Wheeler JE, Enterline HT, Roseman JM, Tomasulo JP, Mcllvaine CH, Fitts WT (1974): Lobular carcinoma in situ of the breast. Long term follow-up. Cancer 34: 554–563

    PubMed  CAS  Google Scholar 

  • Wickerham L, Fisher B, Cronin W (1984): The efficacy of bone scanning in the follow- up of patients with operable breast cancer. Breast Cancer Res Treat 4: 303–307

    PubMed  CAS  Google Scholar 

  • Winchester D, Cox J (1992): Standards for breast conserving treatment, Cancer 42: 134–162

    CAS  Google Scholar 

Download references

Authors
  1. William J. Gradishar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monica Morrow
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, 1901 Perdido Street, 70112-1393, New Orleans, LA, USA

    Wayne V. Vedeckis

  2. Stanley S. Scott Cancer Center, 1901 Perdido Street, 70112-1393, New Orleans, LA, USA

    Wayne V. Vedeckis

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Birkhäuser Boston

About this chapter

Cite this chapter

Gradishar, W.J., Morrow, M. (1996). Clinical Aspects of Breast Cancer. In: Vedeckis, W.V. (eds) Hormones and Cancer. Hormones in Health and Disease. Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-4266-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4266-6_6

  • Publisher Name: Birkhäuser Boston

  • Print ISBN: 978-1-4612-8715-5

  • Online ISBN: 978-1-4612-4266-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation